References
-
1) The interactome of tau phosphorylated at T217 in Alzheimer's disease human brain tissue.
-
2) Enterococcus-derived cytolysin exacerbates ischemic stroke by disrupting the blood-brain barrier via NLRP3 activation.
-
3) Genetically-engineered Salmonella typhimurium expressing FGF21 promotes neurological recovery in ischemic stroke via FGFR1/AMPK/mTOR pathway.
-
4) VSIG2 as a novel immunosuppressive ligand interacts with Nectin-2 to regulate T cell responses.
-
5) IFN-γ signaling links ventriculomegaly to choroid plexus and ependyma dysfunction following maternal immune activation.
-
6) Role of intestinal SCFAs homeostasis in the hepatoprotective effect of Clostridium butyricum in T2DM.
-
7) CDK5 regulates PPARγ/NF-κB signaling to exacerbate obesity-related osteoarthritis via modulating macrophage polarization and chondrocyte apoptosis.
-
8) Immunodynamic axis of fibroblast-driven neutrophil infiltration in acute pancreatitis: NF-κB-HIF-1α-CXCL1.
-
9) Microbiota-derived indole-3-acetic acid alleviates rumen epithelial barrier dysfunction during the peripartum period through AhR signaling.
-
10) Synergistic effects of ferulic acid and wogonin on cholestatic liver injury via gut microbiota modulation.
-
11) Casticin activates Rheb GTPase by binding to residue Trp141 and induces tumor senescence.
-
12) Ferroportin 1 depletion in neural stem cells promotes hippocampal neurogenesis and cognitive function in mice.
-
13) ADAM12 promotes temozolomide resistance in glioblastoma by activating the TNF-α - NF-κB pathway.
-
14) Interleukin-2-inducible T-cell kinase inhibition to block NF-κB signaling exerts anti-tumor effects and enhances chemotherapy in NK/T-cell lymphoma.
-
15) The potential of TAOK1 as a new therapeutic target for the treatment of cancer cachexia-associated muscle atrophy.